Prefer a chat interface with context about you and your work?
Nomogram to Predict Cycle-One Serious Drug-Related Toxicity in Phase I Oncology Trials
All patients in phase I trials do not have equivalent susceptibility to serious drug-related toxicity (SDRT). Our goal was to develop a nomogram to predict the risk of cycle-one SDRT to better select appropriate patients for phase I trials.The prospectively maintained database of patients with solid tumor enrolled onto Cancer …